Hyperlipidemia After Liver Transplantation: Long-term Results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group
Overview
Authors
Affiliations
Cardiovascular effects of immunosuppression agents.
Elezaby A, Dexheimer R, Sallam K Front Cardiovasc Med. 2022; 9:981838.
PMID: 36211586 PMC: 9534182. DOI: 10.3389/fcvm.2022.981838.
Thaiss C, Oura T, Sasaki H, Dehnadi A, Matsunami M, Rosales I Transplantation. 2018; 103(4):689-697.
PMID: 30300283 PMC: 6433526. DOI: 10.1097/TP.0000000000002470.
Chimerism-based tolerance in organ transplantation: preclinical and clinical studies.
Oura T, Cosimi A, Kawai T Clin Exp Immunol. 2017; 189(2):190-196.
PMID: 28369830 PMC: 5508349. DOI: 10.1111/cei.12969.
Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.
Staatz C, Tett S Clin Pharmacokinet. 2004; 43(10):623-53.
PMID: 15244495 DOI: 10.2165/00003088-200443100-00001.
Lipoprotein-apolipoprotein changes in renal transplant recipients.
Cassader M, Ruiu G, Gambino R, Alemanno N, Triolo G, Veglia F Lipids. 2003; 37(10):967-74.
PMID: 12530556 DOI: 10.1007/s11745-006-0988-x.